$TPHS
Trinity Place Holdings Inc. Stock $tphs

$tphs Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000155837022004961 Filed on March 31, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$24.45M	$28.38M	$251.0K
YoY Change	9640.24%	1454.33%	-53.69%
Cost Of Revenue	$3.607M	$7.483M	$2.722M
YoY Change	32.51%	-9.24%	0.63%
Gross Profit	$20.84M	$20.27M	-$2.471M
YoY Change	-943.42%	-390.08%	14.24%
Gross Profit Margin	85.25%	71.43%	-984.46%
Selling, General & Admin	$837.0K	$4.492M	$1.002M
YoY Change	-16.47%	-9.34%	-27.29%
% of Gross Profit	4.02%	22.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$876.0K	$5.137M	$746.0K
YoY Change	17.43%	23.25%	24.33%
% of Gross Profit	4.2%	25.34%
Operating Expenses	$24.15M	$41.24M	$4.268M
YoY Change	465.93%	123.58%	-12.31%
Operating Profit	-$3.313M	-$12.86M	-$4.017M
YoY Change	-17.53%	-269.73%	-177.31%
Interest Expense	-$647.0K	-$3.012M	-$1.291M
YoY Change	-49.88%	95.58%	621.23%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$3.961M	-$17.49M	-$5.308M
YoY Change	-25.38%	-438.31%	-205.82%
Income Tax	$178.0K	$265.0K	$88.00K
% Of Pretax Income
Net Earnings	-$4.139M	-$17.75M	-$5.396M
YoY Change	-23.3%	-465.04%	-206.07%
Net Earnings / Revenue	-16.93%	-62.55%	-2149.8%
Basic Earnings Per Share		-$0.53	-$0.17
Diluted Earnings Per Share	-$117.4K	-$0.53	-$0.16
COMMON SHARES
Basic Shares Outstanding	35.31M	33.32M	32.31K
Diluted Shares Outstanding		33.32M	32.86K

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.310M	$4.310M	$6.515M
YoY Change	-33.84%	-33.84%	-29.15%
Cash & Equivalents	$4.310M	$4.310M	$6.515M
Short-Term Investments
Other Short-Term Assets	$673.0K	$673.0K	$454.0K
YoY Change	48.24%	48.24%	-43.04%
Inventory
Prepaid Expenses
Receivables	$84.00K	$84.00K	$966.0K
Other Receivables	$114.0K	$114.0K	$90.00K
Total Short-Term Assets	$5.181M	$5.181M	$8.025M
YoY Change	-35.44%	-35.44%	-32.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$291.0M	$291.0M	$280.8M
YoY Change	3.66%	3.66%	-4.87%
Goodwill
YoY Change
Intangibles	$8.432M		$9.172M
YoY Change	-8.07%		-7.47%
Long-Term Investments	$4.800M	$17.94M	$5.700M
YoY Change	-15.79%	-7.44%	-46.59%
Other Assets	$20.54M	$20.54M	$9.554M
YoY Change	114.94%	114.94%	0.84%
Total Long-Term Assets	$341.4M	$341.4M	$317.6M
YoY Change	7.5%	6.31%	-4.77%
TOTAL ASSETS
Total Short-Term Assets	$5.181M	$5.181M	$8.025M
Total Long-Term Assets	$341.4M	$341.4M	$317.6M
Total Assets	$346.6M	$346.6M	$325.6M
YoY Change	6.44%	5.3%	-5.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.86M	$17.86M	$15.90M
YoY Change	12.35%	12.38%	-28.52%
Accrued Expenses	$1.447M	$1.447M	$1.716M
YoY Change	-15.68%	-15.68%	-16.9%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$19.31M	$19.31M	$1.716M
YoY Change	1025.35%	9.65%	-98.4%
LONG-TERM LIABILITIES
Long-Term Debt	$270.7M	$270.7M	$242.8M
YoY Change	11.49%	11.49%	38.24%
Other Long-Term Liabilities	$1.146M	$1.146M	$830.0K
YoY Change	38.07%	38.07%	-70.65%
Total Long-Term Liabilities	$271.9M	$271.9M	$243.6M
YoY Change	11.58%	11.58%	36.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.31M	$19.31M	$1.716M
Total Long-Term Liabilities	$271.9M	$271.9M	$243.6M
Total Liabilities	$291.2M	$291.2M	$261.2M
YoY Change	11.45%	11.45%	-8.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$30.79M		-$13.03M
YoY Change	136.21%		-18.53%
Common Stock	$144.7M		$136.4M
YoY Change	6.12%		1.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$57.17M		$56.79M
YoY Change	0.66%		1.9%
Treasury Stock Shares	$6.398M		$6.173M
Shareholders Equity	$55.42M	$55.42M	$64.38M
YoY Change
Total Liabilities & Shareholders Equity	$346.6M	$346.6M	$325.6M
YoY Change	6.44%	5.3%	-5.71%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$4.139M	-$17.75M	-$5.396M
YoY Change	-23.3%	-465.04%	-206.07%
Depreciation, Depletion And Amortization	$876.0K	$5.137M	$746.0K
YoY Change	17.43%	23.25%	24.33%
Cash From Operating Activities	-$5.880M	-$7.443M	-$3.407M
YoY Change	72.59%	-31.39%	307.54%
INVESTING ACTIVITIES
Capital Expenditures	-$5.565M	-$36.35M	-$11.94M
YoY Change	-53.4%	-29.71%	-41.35%
Acquisitions
YoY Change
Other Investing Activities	$20.95M	$22.28M	$5.192M
YoY Change	303.45%	-752.84%	-76.14%
Cash From Investing Activities	$15.38M	-$13.94M	-$6.751M
YoY Change	-327.85%	-74.52%	-584.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$7.269M
YoY Change		-1145.9%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.694M	30.15M	8.063M
YoY Change	-66.59%	-52.09%	635.68%
NET CHANGE
Cash From Operating Activities	-5.880M	-7.443M	-3.407M
Cash From Investing Activities	15.38M	-13.94M	-6.751M
Cash From Financing Activities	2.694M	30.15M	8.063M
Net Change In Cash	12.20M	8.776M	-2.095M
YoY Change	-682.15%	-437.41%	-226.66%
FREE CASH FLOW
Cash From Operating Activities	-$5.880M	-$7.443M	-$3.407M
Capital Expenditures	-$5.565M	-$36.35M	-$11.94M
Free Cash Flow	-$315.0K	$28.91M	$8.536M
YoY Change	-103.69%	-29.27%	-56.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2021Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2020Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2021Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0000724742
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	1-08546
CY2021	dei	Entity Registrant Name EntityRegistrantName	TRINITY PLACE HOLDINGS INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-2465228
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	340 Madison Avenue
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10173
CY2021	dei	City Area Code CityAreaCode	212
CY2021	dei	Local Phone Number LocalPhoneNumber	235-2190
CY2021	dei	Security12b Title Security12bTitle	Common Stock $0.01 Par Value Per Share
CY2021	dei	Trading Symbol TradingSymbol	TPHS
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4126000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	2703000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	19379000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20535000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2020Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2021Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	49736000
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36836146
CY2021	dei	Auditor Firm AuditorFirmId	243
CY2021	dei	Auditor Name AuditorName	BDO USA, LLP
CY2021	dei	Auditor Location AuditorLocation	New York, New York
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	294536000
CY2020Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	279204000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4310000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4126000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2703000
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	17938000
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	84000
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	966000
CY2021Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	114000
CY2020Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	90000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1314000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1565000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8432000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9172000
CY2021Q4	us-gaap	Assets Assets	351389000
CY2020Q4	us-gaap	Assets Assets	329148000
CY2021Q4	us-gaap	Loans Payable LoansPayable	219249000
CY2020Q4	us-gaap	Loans Payable LoansPayable	197330000
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	32844000
CY2020Q4	us-gaap	Line Of Credit LineOfCredit	31858000
CY2021Q4	us-gaap	Secured Debt SecuredDebt	12750000
CY2020Q4	us-gaap	Secured Debt SecuredDebt	7747000
CY2021Q4	us-gaap	Notes Payable NotesPayable	5863000
CY2020Q4	us-gaap	Notes Payable NotesPayable	5863000
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17864000
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	15896000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1447000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1716000
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1146000
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	830000
CY2021Q4	us-gaap	Liabilities Liabilities	291163000
CY2020Q4	us-gaap	Liabilities Liabilities	261240000
CY2020Q4	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2021Q4	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2021Q4	tphs	Special Stock Value SpecialStockValue	0
CY2020Q4	tphs	Special Stock Value SpecialStockValue	0
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1343000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2159000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43024424
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38345540
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36626549
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32172107
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	430000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	383000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	144282000
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	135978000
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	6397875
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	6173433
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	57166000
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	56791000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25977000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9503000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	60226000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	67908000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	351389000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	329148000
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	2600000
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	993000
CY2019	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	4062000
CY2021	us-gaap	Other Income OtherIncome	355000
CY2020	us-gaap	Other Income OtherIncome	263000
CY2019	us-gaap	Other Income OtherIncome	0
CY2021	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	24802000
CY2020	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	0
CY2019	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	0
CY2021	us-gaap	Revenues Revenues	27757000
CY2020	us-gaap	Revenues Revenues	1256000
CY2019	us-gaap	Revenues Revenues	4062000
CY2021	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	7409000
CY2020	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	8166000
CY2019	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	5328000
CY2021	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	74000
CY2020	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	79000
CY2019	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	328000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4492000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4955000
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5349000
CY2021	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	67000
CY2020	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	345000
CY2019	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	733000
CY2021	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	24432000
CY2020	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	0
CY2019	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	0
CY2021	us-gaap	Recapitalization Costs RecapitalizationCosts	5000
CY2020	us-gaap	Recapitalization Costs RecapitalizationCosts	133000
CY2019	us-gaap	Recapitalization Costs RecapitalizationCosts	167000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2864000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2768000
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2977000
CY2021	us-gaap	Operating Expenses OperatingExpenses	39343000
CY2020	us-gaap	Operating Expenses OperatingExpenses	16446000
CY2019	us-gaap	Operating Expenses OperatingExpenses	14882000
CY2021	tphs	Gain Loss On Sale Of School Condominium GainLossOnSaleOfSchoolCondominium	0
CY2020	tphs	Gain Loss On Sale Of School Condominium GainLossOnSaleOfSchoolCondominium	24196000
CY2019	tphs	Gain Loss On Sale Of School Condominium GainLossOnSaleOfSchoolCondominium	0
CY2021	tphs	Gain Loss On Sale Of Real Estate GainLossOnSaleOfRealEstate	0
CY2020	tphs	Gain Loss On Sale Of Real Estate GainLossOnSaleOfRealEstate	0
CY2019	tphs	Gain Loss On Sale Of Real Estate GainLossOnSaleOfRealEstate	9521000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-11586000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	9006000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-1299000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-555000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1571000
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-819000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-73000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-965000
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-3007000
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1398000
CY2019	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	67000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1134000
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	202000
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16209000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6800000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2051000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	265000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	306000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	128000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-16474000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	6494000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-2179000
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	816000
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	1015000
CY2019	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	344000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15658000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7509000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1835000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33322
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32305
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31915
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33322
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32860
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31915
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	59461000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-2179000
CY2019	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-772000
CY2019	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-1992000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1386000
CY2019	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	197000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	59691000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	6494000
CY2020	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-696000
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-1015000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1163000
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	600000
CY2020	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	359000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	67908000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-16474000
CY2021	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-370000
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-816000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7639000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	707000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	60226000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-16474000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	6494000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-2179000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3998000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2970000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2977000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	530000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	806000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	905000
CY2021	tphs	Gain Loss On Sale Of School Condominium GainLossOnSaleOfSchoolCondominium	0
CY2020	tphs	Gain Loss On Sale Of School Condominium GainLossOnSaleOfSchoolCondominium	24196000
CY2019	tphs	Gain Loss On Sale Of School Condominium GainLossOnSaleOfSchoolCondominium	0
CY2021	tphs	Gain Loss On Sale Of Residential Condominiums Net GainLossOnSaleOfResidentialCondominiumsNet	321000
CY2020	tphs	Gain Loss On Sale Of Residential Condominiums Net GainLossOnSaleOfResidentialCondominiumsNet	0
CY2019	tphs	Gain Loss On Sale Of Residential Condominiums Net GainLossOnSaleOfResidentialCondominiumsNet	0
CY2021	tphs	Gain Loss On Sale Of Real Estate GainLossOnSaleOfRealEstate	0
CY2020	tphs	Gain Loss On Sale Of Real Estate GainLossOnSaleOfRealEstate	0
CY2019	tphs	Gain Loss On Sale Of Real Estate GainLossOnSaleOfRealEstate	9521000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	24000
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	84000
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-578000
CY2021	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-816000
CY2020	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-1015000
CY2019	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-1992000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-73000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-965000
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-555000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1571000
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-819000
CY2021	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	885000
CY2020	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	1110000
CY2019	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	33000
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-882000
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-2392000
CY2019	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-1577000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	257000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-190000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-278000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3467000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-686000
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1649000
CY2021	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-1288000
CY2020	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-1033000
CY2019	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-2705000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7304000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10416000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3597000
CY2021	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	36349000
CY2020	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	51715000
CY2019	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	91847000
CY2021	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	22275000
CY2020	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	0
CY2019	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	18812000
CY2021	tphs	Deferred Real Estate Deposits DeferredRealEstateDeposits	0
CY2020	tphs	Deferred Real Estate Deposits DeferredRealEstateDeposits	1971000
CY2019	tphs	Deferred Real Estate Deposits DeferredRealEstateDeposits	33609000
CY2021	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	0
CY2020	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	5383000
CY2019	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	0
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14074000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55127000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39426000
CY2021	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	249984000
CY2020	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	86361000
CY2019	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	55475000
CY2021	tphs	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	8200000
CY2020	tphs	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	5000000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	62942000
CY2019	tphs	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	7250000
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6552000
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1497000
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1531000
CY2021	tphs	Repayment Of Loans Payable RepaymentOfLoansPayable	-225547000
CY2020	tphs	Repayment Of Loans Payable RepaymentOfLoansPayable	-23368000
CY2019	tphs	Repayment Of Loans Payable RepaymentOfLoansPayable	-10557000
CY2021	tphs	Repayment Of Loan And Secured Line Of Credit RepaymentOfLoanAndSecuredLineOfCredit	3200000
CY2020	tphs	Repayment Of Loan And Secured Line Of Credit RepaymentOfLoanAndSecuredLineOfCredit	2500000
CY2019	tphs	Repayment Of Loan And Secured Line Of Credit RepaymentOfLoanAndSecuredLineOfCredit	2000000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	370000
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	695000
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	772000
CY2021	tphs	Proceeds From Stock Buy Back ProceedsFromStockBuyBack	0
CY2020	tphs	Proceeds From Stock Buy Back ProceedsFromStockBuyBack	359000
CY2019	tphs	Proceeds From Stock Buy Back ProceedsFromStockBuyBack	197000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7639000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30154000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	47668000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8776000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2601000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4645000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18670000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14025000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18670000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9196000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11496000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9474000
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2529000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18670000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14025000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4310000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9196000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20535000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9474000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18670000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	16042000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	15495000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	12631000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	395000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	251000
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	352000
CY2021	tphs	Accrued Development Costs Included In Accounts Payable And Accrued Expenses AccruedDevelopmentCostsIncludedInAccountsPayableAndAccruedExpenses	8805000
CY2020	tphs	Accrued Development Costs Included In Accounts Payable And Accrued Expenses AccruedDevelopmentCostsIncludedInAccountsPayableAndAccruedExpenses	10319000
CY2019	tphs	Accrued Development Costs Included In Accounts Payable And Accrued Expenses AccruedDevelopmentCostsIncludedInAccountsPayableAndAccruedExpenses	12698000
CY2021	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	3580000
CY2020	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	2727000
CY2019	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	2737000
CY2021	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	177000
CY2020	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	356000
CY2019	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	480000
CY2021	tphs	Loan Forgiveness Non Cash LoanForgivenessNonCash	243000
CY2020	tphs	Loan Forgiveness Non Cash LoanForgivenessNonCash	0
CY2019	tphs	Loan Forgiveness Non Cash LoanForgivenessNonCash	0
CY2021	tphs	Noncash Investment In Unconsolidated Joint Venture NoncashInvestmentInUnconsolidatedJointVenture	0
CY2020	tphs	Noncash Investment In Unconsolidated Joint Venture NoncashInvestmentInUnconsolidatedJointVenture	5193000
CY2019	tphs	Noncash Investment In Unconsolidated Joint Venture NoncashInvestmentInUnconsolidatedJointVenture	0
CY2021	tphs	Non Cash Right Of Use Assets NonCashRightOfUseAssets	0
CY2020	tphs	Non Cash Right Of Use Assets NonCashRightOfUseAssets	0
CY2019	tphs	Non Cash Right Of Use Assets NonCashRightOfUseAssets	-1904000
CY2021	tphs	Non Cash Lease Liabilities NonCashLeaseLiabilities	0
CY2020	tphs	Non Cash Lease Liabilities NonCashLeaseLiabilities	0
CY2019	tphs	Non Cash Lease Liabilities NonCashLeaseLiabilities	-2065000
CY2021	tphs	Non Cash Warrant Liability NonCashWarrantLiability	0
CY2020	tphs	Non Cash Warrant Liability NonCashWarrantLiability	0
CY2019	tphs	Non Cash Warrant Liability NonCashWarrantLiability	1795000
CY2021	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">NOTE 1 – BASIS OF PRESENTATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">General Business Plan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Trinity Place Holdings Inc., which we refer to in these financial statements as “Trinity,” “we,” “our,” or “us,” is a real estate holding, investment, development and asset management company. Our largest asset is currently a property located at 77 Greenwich Street in Lower Manhattan (“77 Greenwich”), which is nearing completion of development as a mixed-use project consisting of a 90-unit residential condominium tower, retail space and a New York City elementary school. We also own a recently built 105-unit, 12-story multi-family property located at 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street in Brooklyn, New York (“237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>”), and, through joint ventures, a 50% interest in a recently built 95-unit multi-family property known as The Berkley, located at 223 North 8<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street, Brooklyn, New York (“The Berkley”), which is under contract for sale, and a 10% interest in a recently built 234-unit multi-family property located one block from The Berkley at 250 North 10<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street (“250 North 10<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>”) acquired in January 2020, also in Brooklyn, New York. In addition, we own a property occupied by retail tenants in Paramus, New Jersey.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">We also control a variety of intellectual property assets focused on the consumer sector, a legacy of our predecessor, Syms Corp. (“Syms”), including FilenesBasement.com, our rights to the Stanley Blacker® brand, as well as the intellectual property associated with the Running of the Brides® event and An Educated Consumer is Our Best Customer® slogan. In addition, we had approximately $247.5 million of federal net operating loss carryforwards (“NOLs”) at December 31, 2021, which can be used to reduce our future taxable income and capital gains.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Trinity is the successor to Syms, which also owned Filene’s Basement. Syms and its subsidiaries filed for relief under the United States Bankruptcy Code in 2011. In September 2012, the Syms Plan of Reorganization (the “Plan”) became effective and Syms and its subsidiaries consummated their reorganization under Chapter 11 through a series of transactions contemplated by the Plan and emerged from bankruptcy. As part of those transactions, reorganized Syms merged with and into Trinity, with Trinity as the surviving corporation. We completed our final payment and reserve obligations under the Plan in March 2016.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">On January 18, 2018, Syms and certain of its subsidiaries (the “Reorganized Debtors”) filed with the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) a motion for entry of a final decree (the “Final Decree”) (i) closing the chapter 11 cases of the Reorganized Debtors; and (ii) retaining the Bankruptcy Court’s jurisdiction as provided for in the Plan, including to enforce or interpret its own orders pertaining to the chapter 11 cases including, but not limited to, the Plan and Final Decree, among other matters. On February 6, 2018, the Bankruptcy Court entered the Final Decree closing the chapter 11 cases of the Reorganized Debtors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Square footage, leased occupancy percentage and residential unit disclosures in the notes to consolidated financial statements are unaudited.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">COVID-19 Pandemic, Management’s Plans and Liquidity</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">As a result of the COVID-19 pandemic, numerous federal, state, local and foreign governmental authorities issued a range of “stay-at-home orders”, proclamations and directives aimed at minimizing the spread of COVID-19, among other restrictions on businesses and individuals. Additional proclamations and directives have been issued in response to further outbreaks, and may be issued in the future. The outbreak and restrictions have adversely affected our business operations including, among other things, a temporary suspension of construction work at our most significant asset, 77 Greenwich, which resumed in mid-April 2020, initially on a modified basis as certain work was deemed “essential” construction, and the temporary closing of the sales center for the 77 Greenwich residential condominium units as well as the temporary suspension of the remediation work being performed on 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>, which resumed in early June 2020 and was completed in the fourth quarter of 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The economic downturn and volatility in financial markets appear to have been primarily driven by uncertainties associated with the pandemic. As it relates to our business, these uncertainties include, but are not limited to, the adverse effect of the pandemic on the New York City and broader economy, residential and potential residential sentiment in New York City, particularly Manhattan, lending institutions, construction and material supply partners, travel and transportation services, our employees, residents and tenants, and traffic to and within geographic areas containing our real estate assets. The pandemic has adversely affected our near-term, and may adversely affect our long-term, liquidity, cash flows and revenues and has required and may continue to require significant actions in response, including, but not limited to, reducing or discounting prices for our residential condominium units more than originally budgeted, seeking loan extensions and covenant modifications, modifying, eliminating or deferring rent payments in the short term for tenants in an effort to mitigate financial hardships and seeking access to federal, state and/or local financing and other programs in 2020 and 2021. We were also subject </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">to a New York State mandate disallowing tenant evictions for non-payment of rent due to COVID-19 related hardships throughout 2021, which was recently lifted on January 15, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The ultimate impact of the COVID-19 pandemic on our operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak, recurring outbreaks, new information which may emerge concerning the pandemic and any additional preventative and protective actions that governments, lending institutions and other businesses, including us, may direct or institute. These and other developments have resulted in and are expected to result in an extended period of continued business disruption and reduced operations for us as well as for lending and other businesses and governmental entities with which we do business. The ultimate financial impacts cannot be reasonably estimated at this time but the outbreak, restrictions and future developments are anticipated to continue to have an adverse impact on our business, financial condition and results of operations, which has been and may continue to be material, although in recent months we have seen indications of a recovery in the New York City real estate market and improvements in the financing markets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The measures taken to date, together with any additional measures and developments including those noted above, impacted and will continue to impact the Company’s business in 2022 and beyond, although the extent of the significance of the impact of the COVID-19 outbreak on our business and the duration for which it may have an impact cannot be determined at this time. Although the impact of the pandemic has impeded the sale of residential condominium units at 77 Greenwich, we have closed on 14 residential condominium units in 2021 and have closed on three additional residential condominium units as of March 31, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">As of December 31, 2021, we had total cash and restricted cash of $24.8 million, of which approximately $4.3 million was cash and cash equivalents and approximately $20.5 million was restricted cash. At this time, we believe our existing balances of cash and cash equivalents, together with proceeds that may be raised from the sale of The Berkley, which is under contract, subject to usual closing conditions and currently anticipated to close in April 2022, planned refinancing of the Paramus line of credit, or sale of the Paramus property and sales of the larger, higher floor condominium units at 77 Greenwich will be sufficient to satisfy our working capital needs and projected capital and other expenditures associated with our operations over the next 12 months, and the Company has concluded that management’s current plan alleviates the substantial doubt about its ability to continue as a going concern. Additionally, we continue to evaluate opportunities to raise capital through sales of equity, including under our ATM program, debt issuances or refinancings, including refinancing the property located at 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street, and continue to evaluate dispositions of other properties or other assets and/or sales of partial interests in properties. Facts and circumstances could change in the future that are outside of management’s control, such as additional government mandates, health official orders, travel restrictions and extended business shutdowns due to COVID-19, and the impact of such matters on residential sentiment in New York City in particular.</p>
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24800000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4300000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20500000
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 18pt;">c. <i style="font-style:italic;">Use of Estimates</i> - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates.</p>
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 18pt;">e. <i style="font-style:italic;">Concentrations of Credit Risk</i> - Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. We hold substantially all of our cash and cash equivalents in banks. Such cash balances at times exceed federally insured limits.</p>
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.31
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	2900000
CY2020Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	3900000
CY2021	tphs	Error Correction Related To Capitalization Of General Advertising And Marketing Expenses ErrorCorrectionRelatedToCapitalizationOfGeneralAdvertisingAndMarketingExpenses	2400000
CY2021Q4	us-gaap	Development In Process DevelopmentInProcess	230078000
CY2020Q4	us-gaap	Development In Process DevelopmentInProcess	213178000
CY2021Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	41358000
CY2020Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	41358000
CY2021Q4	us-gaap	Tenant Improvements TenantImprovements	200000
CY2020Q4	us-gaap	Tenant Improvements TenantImprovements	189000
CY2021Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	775000
CY2020Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	731000
CY2021Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	27939000
CY2020Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	27939000
CY2021Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	300350000
CY2020Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	283395000
CY2021Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	5814000
CY2020Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	4191000
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	294536000
CY2020Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	279204000
CY2019	us-gaap	Depreciation Depreciation	1600000
CY2020	us-gaap	Depreciation Depreciation	1600000
CY2021	us-gaap	Depreciation Depreciation	1600000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11100000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11100000
CY2021	tphs	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	2700000
CY2020	tphs	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	1900000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	740000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	740000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	740000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	265000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	306000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	128000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	265000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	306000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	128000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	740000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	740000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	740000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	740000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	740000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	4732000
CY2019Q4	tphs	Gross Sales Price Of Sale Of Real Estate GrossSalesPriceOfSaleOfRealEstate	19600000
CY2019Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	10600000
CY2019Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	9500000
CY2021Q4	tphs	Aggregate Fees Paid By Sca To Company AggregateFeesPaidByScaToCompany	46100000
CY2021Q4	tphs	Remaining Fees To Be Paid By Sca To Company RemainingFeesToBePaidByScaToCompany	450000
CY2020Q2	tphs	Gain On Sale Of School Condominium Excluding Deferred Construction Supervision Fee GainOnSaleOfSchoolCondominiumExcludingDeferredConstructionSupervisionFee	20000000.0
CY2020Q2	tphs	Gain On Sale Of School Condominium Deferred Construction Supervision Fee GainOnSaleOfSchoolCondominiumDeferredConstructionSupervisionFee	4200000
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	673000
CY2020Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	454000
CY2021Q4	tphs	Deferred Finance Costs DeferredFinanceCosts	2184000
CY2020Q4	tphs	Deferred Finance Costs DeferredFinanceCosts	1795000
CY2021Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	2736000
CY2020Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	954000
CY2021Q4	tphs	Prepaid Expense And Other Assets Gross PrepaidExpenseAndOtherAssetsGross	5593000
CY2020Q4	tphs	Prepaid Expense And Other Assets Gross PrepaidExpenseAndOtherAssetsGross	3203000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1467000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	500000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	265000
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3273000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	253000
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	306000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	128000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.158
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.063
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.497
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.004
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.050
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.056
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.381
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.278
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.713
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.017
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.045
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.062
CY2021Q4	tphs	Deferred Tax Liabilities Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxLiabilitiesTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1000
CY2020Q4	tphs	Deferred Tax Liabilities Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxLiabilitiesTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	15000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	64404000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	58635000
CY2021Q4	tphs	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Depreciation DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDepreciation	4664000
CY2020Q4	tphs	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Depreciation DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDepreciation	4677000
CY2021Q4	tphs	Deferred Tax Assets Tax Deferred Lease Liability DeferredTaxAssetsTaxDeferredLeaseLiability	507000
CY2020Q4	tphs	Deferred Tax Assets Tax Deferred Lease Liability DeferredTaxAssetsTaxDeferredLeaseLiability	571000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	247000
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	160000
CY2021Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	777000
CY2020Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	678000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	332000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	132000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	70932000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	64868000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	66605000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	60930000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4327000
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3938000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3003000
CY2021	tphs	Deferred Tax Asset Net Noncurrent DeferredTaxAssetNetNoncurrent	0
CY2020	tphs	Deferred Tax Asset Net Noncurrent DeferredTaxAssetNetNoncurrent	0
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2021	us-gaap	Tax Credit Carryforward Limitations On Use TaxCreditCarryforwardLimitationsOnUse	Pursuant to the tax legislation known as the Tax Cuts and Jobs Act (the "TCJA") of 2017, corporate alternative minimum tax (“AMT”) credit carryforwards are eligible for a 50% refund in tax years 2018 through 2020
CY2019Q4	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	1600000
CY2020Q3	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	1500000
CY2021Q4	tphs	Federal Net Operating Loss Carryforwards Utilized To Date FederalNetOperatingLossCarryforwardsUtilizedToDate	23800000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	66600000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	60900000
CY2021Q4	tphs	Deferred Tax Liabilities Pension Cost DeferredTaxLiabilitiesPensionCost	571000
CY2020Q4	tphs	Deferred Tax Liabilities Pension Cost DeferredTaxLiabilitiesPensionCost	114000
CY2021Q4	tphs	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	500000
CY2020Q4	tphs	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	551000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	4327000
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3938000
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2021	tphs	Deferred Tax Asset Net Current DeferredTaxAssetNetCurrent	0
CY2020	tphs	Deferred Tax Asset Net Current DeferredTaxAssetNetCurrent	0
CY2021	tphs	Number Of Retail Lease Signed Expires NumberOfRetailLeaseSignedExpires	1
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	3267000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	1010000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	453000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	477000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	487000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	2615000
CY2021Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	8309000
CY2021Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	15900000
CY2020Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	14224000
CY2019Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	13933000
CY2021	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	665000
CY2020	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	658000
CY2021	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	344000
CY2020	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	408000
CY2021	tphs	Defined Benefit Plan Benefits Received Paid DefinedBenefitPlanBenefitsReceivedPaid	-925000
CY2020	tphs	Defined Benefit Plan Benefits Received Paid DefinedBenefitPlanBenefitsReceivedPaid	-775000
CY2021Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	14308000
CY2020Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	14224000
CY2020Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	14568000
CY2019Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	13009000
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	400000
CY2020	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	400000
CY2021	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	925000
CY2020	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	775000
CY2021	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	1897000
CY2020	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	1934000
CY2021Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	15940000
CY2020Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	14568000
CY2021Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	1632000
CY2020Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	344000
CY2021	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	665000
CY2020	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	658000
CY2019	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	644000
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	925000
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	974000
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	1026000
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	1085000
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	1152000
CY2021Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	4854000
CY2021	tphs	Defined Benefit Plan Gain Loss On Plan Assets DefinedBenefitPlanGainLossOnPlanAssets	-842000
CY2020	tphs	Defined Benefit Plan Gain Loss On Plan Assets DefinedBenefitPlanGainLossOnPlanAssets	-758000
CY2019	tphs	Defined Benefit Plan Gain Loss On Plan Assets DefinedBenefitPlanGainLossOnPlanAssets	-628000
CY2021	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-105000
CY2020	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-247000
CY2019	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-484000
CY2021	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-72000
CY2020	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	147000
CY2019	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	500000
CY2021Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.050
CY2020Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.050
CY2019Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.050
CY2021	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.000
CY2020	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.000
CY2019	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.000
CY2019	tphs	Expected Long Term Rate Of Return ExpectedLongTermRateOfReturn	0.06
CY2020	tphs	Expected Long Term Rate Of Return ExpectedLongTermRateOfReturn	0.06
CY2021	tphs	Expected Long Term Rate Of Return ExpectedLongTermRateOfReturn	0.06
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	69000
CY2020	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	71000
CY2019	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	67000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	470000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	470000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	470000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	116000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1526000
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	278731000
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8025000
CY2021Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	270706000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	79000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1447000
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	3800000
CY2022Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	413000
CY2020Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1500000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	10000000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	202710000
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	66021000
CY2021	us-gaap	Interest Costs Incurred InterestCostsIncurred	21238000
CY2020	us-gaap	Interest Costs Incurred InterestCostsIncurred	17174000
CY2019	us-gaap	Interest Costs Incurred InterestCostsIncurred	13513000
CY2021	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	18229000
CY2020	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	15719000
CY2019	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	13513000
CY2021	us-gaap	Interest Income Other InterestIncomeOther	2000
CY2020	us-gaap	Interest Income Other InterestIncomeOther	57000
CY2019	us-gaap	Interest Income Other InterestIncomeOther	67000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-3007000
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1398000
CY2019	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	67000
CY2021Q4	tphs	Capital Stock Shares Authorized CapitalStockSharesAuthorized	120000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2021Q4	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	483361
CY2021	tphs	Stock Repurchase Program Average Price Per Share StockRepurchaseProgramAveragePricePerShare	1.93
CY2021Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	4500000
CY2021Q4	tphs	Special Stock Shares Authorized SpecialStockSharesAuthorized	1
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43024424
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38345540
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36626549
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32172107
CY2019Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P10Y
CY2019Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	7179000
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.50
CY2019Q4	tphs	Warrant Agreement Threshold Minimum Beneficial Ownership Percentage WarrantAgreementThresholdMinimumBeneficialOwnershipPercentage	0.05
CY2019Q4	tphs	Warrant Agreement Threshold Maximum Percentage Of Issued And Outstanding Common Stock After Exercise Of Warrants WarrantAgreementThresholdMaximumPercentageOfIssuedAndOutstandingCommonStockAfterExerciseOfWarrants	0.199
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.31
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1100000
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	830000
CY2021	tphs	Unrealized Gain Loss On Warrants UnrealizedGainLossOnWarrants	-73000
CY2020	tphs	Unrealized Gain Loss On Warrants UnrealizedGainLossOnWarrants	-965000
CY2021Q4	tphs	Warrant Holder S Right Number Of Board Members To Appoint WarrantHolderSRightNumberOfBoardMembersToAppoint	1
CY2021	tphs	Warrant Agreement Preemptive Rights Period WarrantAgreementPreemptiveRightsPeriod	P5Y
CY2021Q4	tphs	Warrant Agreement Threshold Minimum Beneficial Ownership Percentage WarrantAgreementThresholdMinimumBeneficialOwnershipPercentage	0.05
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2650000
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.90
CY2019Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000.0
CY2021	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	250197
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	548370
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1017535
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1500000
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	107754
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Exercise Price DeferredCompensationArrangementWithIndividualExercisePrice	1.77
CY2020	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	114005
CY2020	us-gaap	Deferred Compensation Arrangement With Individual Exercise Price DeferredCompensationArrangementWithIndividualExercisePrice	1.76
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1569449
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	548370
CY2021Q4	us-gaap	Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Carrying Costs RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionCarryingCosts	211897000
CY2021	tphs	Realestate And Accumulated Depreciation Buildings And Improvements RealestateAndAccumulatedDepreciationBuildingsAndImprovements	156000
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2020Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.070
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	4800000
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	77000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.01
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	227917
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	3.59
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	279834
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	5.46
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	551083
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.14
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	469000
CY2021Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Land RealEstateAndAccumulatedDepreciationCarryingAmountOfLand	27939000
CY2021Q4	tphs	Real Estate And Accumulated Depreciation Carrying Amount Of Air Rights RealEstateAndAccumulatedDepreciationCarryingAmountOfAirRights	230078000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.43
CY2021Q4	tphs	Deferred Compensation Arrangement With Individual Shares Outstanding DeferredCompensationArrangementWithIndividualSharesOutstanding	284913
CY2020Q4	tphs	Deferred Compensation Arrangement With Individual Shares Outstanding DeferredCompensationArrangementWithIndividualSharesOutstanding	177159
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	469000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.43
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	453334
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.00
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	310000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.25
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	295500
CY2021Q4	srt	Real Estate And Accumulated Depreciation Amount Of Encumbrances RealEstateAndAccumulatedDepreciationAmountOfEncumbrances	222177000
CY2021Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Land RealEstateAndAccumulatedDepreciationInitialCostOfLand	27939000
CY2021Q4	tphs	Real Estate And Accumulated Depreciation Initial Cost Of Air Rights RealEstateAndAccumulatedDepreciationInitialCostOfAirRights	18181000
CY2021Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements	42177000
CY2021Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Buildings And Improvements RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements	42333000
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	300350000
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	5814000
CY2021Q4	tphs	Deferred Offering Costs Net DeferredOfferingCostsNet	4900000
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	283395000
CY2019Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	295803000
CY2021	us-gaap	Real Estate Acquisitions Through Foreclosures RealEstateAcquisitionsThroughForeclosures	38861000
CY2020	us-gaap	Real Estate Acquisitions Through Foreclosures RealEstateAcquisitionsThroughForeclosures	51715000
CY2021	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	21906000
CY2020	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	64123000
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	300350000
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	283395000
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	4191000
CY2019Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	2577000
CY2021	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	1623000
CY2020	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	1614000
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	5814000
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	4191000

Files In Submission

Name	View Source	Status
0001558370-22-004961-index-headers.html	Edgar Link	pending
0001558370-22-004961-index.html	Edgar Link	pending
0001558370-22-004961.txt	Edgar Link	pending
0001558370-22-004961-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tphs-20211231.xsd	Edgar Link	pending
tphs-20211231x10k.htm	Edgar Link	pending
tphs-20211231x10k_htm.xml	Edgar Link	completed
tphs-20211231xex21d1.htm	Edgar Link	pending
tphs-20211231xex23d1.htm	Edgar Link	pending
tphs-20211231xex31d1.htm	Edgar Link	pending
tphs-20211231xex31d2.htm	Edgar Link	pending
tphs-20211231xex32d1.htm	Edgar Link	pending
tphs-20211231xex32d2.htm	Edgar Link	pending
tphs-20211231_cal.xml	Edgar Link	unprocessable
tphs-20211231_def.xml	Edgar Link	unprocessable
tphs-20211231_lab.xml	Edgar Link	unprocessable
tphs-20211231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TPHS
Trinity Place Holdings Inc. Stock $tphs

2021 Q4 Form 10-K Financial Statement

#000155837022004961 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TPHS Trinity Place Holdings Inc. Stock $tphs

2021 Q4 Form 10-K Financial Statement

#000155837022004961 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TPHS
Trinity Place Holdings Inc. Stock $tphs